Ross Operation in Children: Late Results
Ronald C. Elkins MD, Mary M. Lane PhD, Carolyn McCue RN

The Ross operation has proven to be the preferred aortic valve replacement in children. Actuarial survival is 92 ± 3% at 12 years, actuarial freedom from autograft valve degeneration is 90 ± 4% at 12 years, from autograft replacement is 93 ± 3% at 12 years, from homograft valve replacement is 90 ± 4% at 12 years, and from all valve-related morbidity is 79 ± 5% at 11 years. The Ross operation allows the child to have an excellent lifestyle with minimal restrictions and minimal need for continuing medical care, other than routine surveillance.